Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia
published in: Haematologica
date of publication: 2015-01-16
main subject: lymphocyte, leukemia, chronic lymphocytic leukemia
Cites articles 22
Date
Title
Article - wd:Q33419843